OLMA long pos, buy- 13.65$, target- 30$OLMA long pos, buy- 13.65$, target- 30$
Not a recommendation, my personal opinion only
Next report date
Report period
Q1 2024
EPS estimate
−0.54USD
Revenue estimate
—
−2.16USD
−96.66 MUSD
48.58 M
About Olema Pharmaceuticals, Inc.
Sector
CEO
Sean P. Bohen
Headquarters
San Francisco
Website
Employees (FY)
74
Founded
2006
FIGI
BBG00T5JMRT4
Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.
Olema Pharmaceuticals: Enjoy!Olema is currently developing a "cancer" drug that suppresses the body's production of Estrogen. Now this could be useful for breast cancer treatment but the real target audience, in my opinion, is hormone replacement therapy for gender transition. I don't necessarily endorse this kind of product bu
OLMA Bullish DivergencePrice tested prior resistance and bounced with a tremendous volume spike.
OBV has bullish divergence since the downtrend began in late Feb.
Looking for support to hold (2.99) and price to break 3.49 to enter a swing trade.
target: 3.80, 4.06, 4.67
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of OLMA is 9.95 USD — it has increased by 1.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Olema Pharmaceuticals, Inc. stocks are traded under the ticker OLMA.
Olema Pharmaceuticals, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
OLMA stock is 6.10% volatile and has beta coefficient of 1.70. Check out the list of the most volatile stocks — is Olema Pharmaceuticals, Inc. there?
OLMA earnings for the last quarter are −0.48 USD per share, whereas the estimation was −0.51 USD resulting in a 6.18% surprise. The estimated earnings for the next quarter are −0.48 USD per share. See more details about Olema Pharmaceuticals, Inc. earnings.
Yes, you can track Olema Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
OLMA stock has risen by 1.43% compared to the previous week, the month change is a 9.63% fall, over the last year Olema Pharmaceuticals, Inc. has showed a 128.74% increase.
OLMA net income for the last quarter is −26.77 M USD, while the quarter before that showed −21.50 M USD of net income which accounts for −24.51% change. Track more Olema Pharmaceuticals, Inc. financial stats to get the full picture.
Today Olema Pharmaceuticals, Inc. has the market capitalization of 549.64 M, it has decreased by 8.78% over the last week.
No, OLMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OLMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Olema Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 74.00 employees. See our rating of the largest employees — is Olema Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Olema Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Olema Pharmaceuticals, Inc. stock shows the sell signal. See more of Olema Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Olema Pharmaceuticals, Inc. future price: according to them, OLMA price has a max estimate of 32.00 USD and a min estimate of 20.00 USD. Read a more detailed Olema Pharmaceuticals, Inc. forecast: see what analysts think of Olema Pharmaceuticals, Inc. and suggest that you do with its stocks.